ID A0A090IB53_9GAMM Unreviewed; 1052 AA.
AC A0A090IB53;
DT 26-NOV-2014, integrated into UniProtKB/TrEMBL.
DT 26-NOV-2014, sequence version 1.
DT 24-JAN-2024, entry version 30.
DE SubName: Full=AcrB/AcrD/AcrF family protein {ECO:0000313|EMBL:SGZ17811.1};
DE SubName: Full=Multidrug resistance protein {ECO:0000313|EMBL:CED58991.1};
GN ORFNames=MVIS_0985 {ECO:0000313|EMBL:CED58991.1}, NVI5450_4580
GN {ECO:0000313|EMBL:SGZ17811.1};
OS Moritella viscosa.
OC Bacteria; Pseudomonadota; Gammaproteobacteria; Alteromonadales;
OC Moritellaceae; Moritella.
OX NCBI_TaxID=80854 {ECO:0000313|EMBL:CED58991.1, ECO:0000313|Proteomes:UP000032438};
RN [1] {ECO:0000313|EMBL:CED58991.1}
RP NUCLEOTIDE SEQUENCE.
RA Hjerde Erik;
RL Submitted (SEP-2014) to the EMBL/GenBank/DDBJ databases.
RN [2] {ECO:0000313|Proteomes:UP000032438}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA Hjerde E.;
RL Submitted (SEP-2014) to the EMBL/GenBank/DDBJ databases.
RN [3] {ECO:0000313|EMBL:SGZ17811.1, ECO:0000313|Proteomes:UP000183794}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=NVI 5450 {ECO:0000313|EMBL:SGZ17811.1};
RA Jaros S., Januszkiewicz K., Wedrychowicz H.;
RL Submitted (NOV-2016) to the EMBL/GenBank/DDBJ databases.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; LN554852; CED58991.1; -; Genomic_DNA.
DR EMBL; FPLD01000131; SGZ17811.1; -; Genomic_DNA.
DR RefSeq; WP_045109376.1; NZ_FRDV01000033.1.
DR STRING; 80854.MVIS_0985; -.
DR KEGG; mvs:MVIS_0985; -.
DR PATRIC; fig|80854.5.peg.1045; -.
DR HOGENOM; CLU_002755_1_2_6; -.
DR OrthoDB; 9757904at2; -.
DR Proteomes; UP000032438; Chromosome complete sequence.
DR Proteomes; UP000183794; Unassembled WGS sequence.
DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR GO; GO:0022857; F:transmembrane transporter activity; IEA:InterPro.
DR Gene3D; 3.30.70.1430; Multidrug efflux transporter AcrB pore domain; 2.
DR Gene3D; 3.30.70.1440; Multidrug efflux transporter AcrB pore domain; 1.
DR Gene3D; 3.30.70.1320; Multidrug efflux transporter AcrB pore domain like; 1.
DR Gene3D; 1.20.1640.10; Multidrug efflux transporter AcrB transmembrane domain; 2.
DR InterPro; IPR027463; AcrB_DN_DC_subdom.
DR InterPro; IPR001036; Acrflvin-R.
DR PANTHER; PTHR32063; -; 1.
DR PANTHER; PTHR32063:SF29; HAE1 FAMILY EFFLUX PUMP PERMEASE COMPONENT; 1.
DR Pfam; PF00873; ACR_tran; 1.
DR PRINTS; PR00702; ACRIFLAVINRP.
DR SUPFAM; SSF82866; Multidrug efflux transporter AcrB transmembrane domain; 2.
PE 4: Predicted;
KW Membrane {ECO:0000256|SAM:Phobius};
KW Reference proteome {ECO:0000313|Proteomes:UP000032438};
KW Transmembrane {ECO:0000256|ARBA:ARBA00022692, ECO:0000256|SAM:Phobius};
KW Transmembrane helix {ECO:0000256|ARBA:ARBA00022989,
KW ECO:0000256|SAM:Phobius}.
FT TRANSMEM 334..353
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 360..380
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 386..411
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 431..451
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 463..486
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 524..543
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 853..872
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 879..899
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 905..926
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 954..974
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
FT TRANSMEM 980..1001
FT /note="Helical"
FT /evidence="ECO:0000256|SAM:Phobius"
SQ SEQUENCE 1052 AA; 113557 MW; CF60B8CE1FA54078 CRC64;
MWLSDTSVKR PVVAIVLSLL LCVFGAVSFS KLAVREMPDV ESPVVSVMTR YEGAAASIME
SQVTSVIEDQ ITGISGIDEV SSVTRNGMSR ITVTFDLGWN LTEGVSDIRD AVAKAQRSLP
NEADDPIVSK DNGNGEPSVY INLNSTEMDR TQLTDYAQRV LEDRFSLISG VSSVGLSGGL
YQVMYVKLFP DLMAGRAVTT SDIVTALKTD NVENPGGEVR NDTTVMSVRT ARLYDQPKDF
EYLVVRTASD GSPVYLRDVA QVYVGAQNKS SSFKSNGIVN LSLGIVAQSD ANPLDVANAV
HDEVDKMQSF LPKGMNLAVD YDSTVFIDQS ISEVYSTLFI TGGLVVLVLY IFIGQARATL
IPAVTVPVSL ISSFITAYYF GFSINLITLM ALILSIGLVV DDAIVVIENI FHHIDQGEKP
LLAAYKGTRE VGFAVVATTM VLVMVFLPIS FMDGMVGLLF TEFSVLLAMS VIFSSLIALT
LTPVLASKML KTEQKTSRFS LWMEGLFERL ENGYRGIVVK AIKYRLAAPV VIIACVVGSF
LLMKQVPSQL SPQEDRGVLF AFVKGAEGTS FNRMTANMDI VEARLLPLVG QGVIKSFSTE
APAFGGRAGD QTGFVIIILE DWSDRTVSAG EALGMVAKAL KDIPDVMVRP IMPGFRGGSG
DPVQYVLGGS DYSELEKWAE LLKQKAEDAG VLVGGDLDYS EKTPELVVSI DKERAGELGI
SVDEVSTTLE IMLGGRSETS YIERGEEYDV YLRGDENSFN NVNDLSQIYI RSANGNLITL
DTISTIEEVA SASRLSHSNK QKSITLSSSL GDGYTLGEVL DFLDAQAIES LPSDISIAYS
GESKDFKENQ SSILIVFGLA LLVAYLVLAA QFESFINPMV VMFTVPMGVL GGFLGLYFMG
VGLNIYSQIG MIMLIGMVTK NGILIVEFAN QLRDRGVALE QAIIDASARR LRPILMTAFT
TLAGSIPLIL SSGAGAESRV AVGTVVFFGM AFATLVTLLV IPAMYRLISG ATHSPGYVEA
MLEVELAEQS GKLLSERSAR QVKDVHVVKD VA
//
